Argo Therapeutics
PrivateLast Round
Accelerator
Nov 10, 2020
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Argo Therapeutics is a biotechnology company that develops first-in-class therapies for neurodegenerative diseases such as ALS and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Argo Therapeutics Comparables
Compare Argo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Topos Bio | 86% | |
| Verge Genomics | 84% | |
| Brenig Therapeutics | 82% | |
Argo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 10, 2020 |
Key People
Founding team and executive leadership
Argo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BaseLaunch | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 559% MoM, from 273 to 1.8K.
- Jun 20, 2026
Monthly visitors grew 237% MoM, reaching 273.
Argo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Argo Therapeutics's valuation, stock price, and market status.